The CMD technology is protected by a portfolio of patents
1: Devices and methods for detecting beta-haematin and haemozoin (CN101600962B, EP2082223B1, EP3486651B1 and US8214006B2)
2: Method and device for detecting an analyte (EP2751546B1 and US10551374B2)
3: Magneto-optical method and apparatus for detecting analytes in a liquid (GB2565622B, GB2566995B, US11561173B2 and EP3688444A1)
4: aBET trademark (UK00003277293)